Personal tools

MCL coexpression mm9:1117: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004177!1.60e-17!29;UBERON:0005057!1.60e-17!29;UBERON:0002370!1.48e-16!23;UBERON:0000974!1.48e-16!23;UBERON:0004807!1.48e-16!23;UBERON:0005058!1.48e-16!23;UBERON:0003351!1.48e-16!23;UBERON:0009113!1.48e-16!23;UBERON:0003295!1.48e-16!23;UBERON:0009722!1.48e-16!23;UBERON:0005562!1.48e-16!23;UBERON:0007690!1.48e-16!23;UBERON:0000065!2.41e-16!41;UBERON:0001004!8.55e-16!42;UBERON:0006562!1.15e-15!24;UBERON:0003408!1.15e-15!24;UBERON:0001557!1.15e-15!24;UBERON:0001042!1.15e-15!24;UBERON:0008814!1.15e-15!24;UBERON:0009145!1.15e-15!24;UBERON:0000077!1.49e-13!35;UBERON:0000072!2.11e-13!27;UBERON:0002193!7.32e-13!48;UBERON:0002405!7.32e-13!48;UBERON:0001041!7.40e-13!80;UBERON:0001007!1.81e-12!116;UBERON:0001555!1.81e-12!116;UBERON:0007026!1.81e-12!116;UBERON:0004119!4.42e-12!118;UBERON:0000925!4.42e-12!118;UBERON:0006595!4.42e-12!118;UBERON:0004921!5.56e-12!114;UBERON:0002390!1.79e-11!45;UBERON:0003061!1.79e-11!45;UBERON:0005911!7.30e-11!69;UBERON:0000063!1.21e-10!35;UBERON:0007811!6.43e-09!36;UBERON:0003929!1.23e-07!55;UBERON:0000153!8.92e-07!43
|ontology_enrichment_uberon=UBERON:0004177!1.60e-17!29;UBERON:0005057!1.60e-17!29;UBERON:0002370!1.48e-16!23;UBERON:0000974!1.48e-16!23;UBERON:0004807!1.48e-16!23;UBERON:0005058!1.48e-16!23;UBERON:0003351!1.48e-16!23;UBERON:0009113!1.48e-16!23;UBERON:0003295!1.48e-16!23;UBERON:0009722!1.48e-16!23;UBERON:0005562!1.48e-16!23;UBERON:0007690!1.48e-16!23;UBERON:0000065!2.41e-16!41;UBERON:0001004!8.55e-16!42;UBERON:0006562!1.15e-15!24;UBERON:0003408!1.15e-15!24;UBERON:0001557!1.15e-15!24;UBERON:0001042!1.15e-15!24;UBERON:0008814!1.15e-15!24;UBERON:0009145!1.15e-15!24;UBERON:0000077!1.49e-13!35;UBERON:0000072!2.11e-13!27;UBERON:0002193!7.32e-13!48;UBERON:0002405!7.32e-13!48;UBERON:0001041!7.40e-13!80;UBERON:0001007!1.81e-12!116;UBERON:0001555!1.81e-12!116;UBERON:0007026!1.81e-12!116;UBERON:0004119!4.42e-12!118;UBERON:0000925!4.42e-12!118;UBERON:0006595!4.42e-12!118;UBERON:0004921!5.56e-12!114;UBERON:0002390!1.79e-11!45;UBERON:0003061!1.79e-11!45;UBERON:0005911!7.30e-11!69;UBERON:0000063!1.21e-10!35;UBERON:0007811!6.43e-09!36;UBERON:0003929!1.23e-07!55;UBERON:0000153!8.92e-07!43
|tfbs_overrepresentation_for_novel_motifs=0.438063,0.0418382,0.411716,0.480627,0.810002,0.495263,0.587291,0.206208,0.616096,0.219671,0.542749,0.575086,0.206435,0.599731,0.847296,0,0.795315,0.291368,0.561256,0.112498,0.374752,0.08187,0.598814,0.29769,0.419327,0.62766,0.184473,0.516511,0.344372,0.446946,0.50223,0.897561,0.289148,0.166577,0.316253,0.101236,2.14888,0.57142,0.258564,0.652422,0.295233,0.507468,0.0742755,0.317766,0.277561,0.469348,0.714592,0.532496,0.219744,0.347313,0.777641,0.654933,0.431711,1.04034,1.0579,0.606984,0.356236,0.56214,0.176152,1.47148,0.877332,0.664501,0.226529,0.766235,0.618279,0.807219,1.19497,1.54543,0.872612,1.39786,0.392734,0.21183,1.02583,1.09164,0.17012,0.159969,0.166511,1.67636,0.859987,0.378988,0.212973,0.812889,0.663039,1.09903,0.975495,0.0369809,5.12627,0.145788,0.719558,1.70793,1.26498,0.980512,0.910485,0.305079,0.254625,0.237542,0.589174,0.913319,0.71485,0.127063,0.280055,0.897279,1.02279,0.778243,0.777175,0.507021,0.837607,0.528416,0.383871,0.376549,0.430942,1.02459,0.380122,0.547992,1.27206,0.796976,0.0501572,0.484437,0.796633,0.276329,1.09707,0.745011,1.52304,0.702145,1.32639,0.863723,0.595563,0.903645,1.19345,0.308038,1.00568,0.473246,1.16374,0.620831,1.29374,0.0806013,0.446555,0.508896,1.24438,2.07659,1.67603,1.19971,0.641722,0.908128,0.770616,0.507927,0.717753,2.03691,0.448938,0.300961,0.147909,0.256263,1.04192,0.243291,0.619892,1.12411,0.655955,0.327731,0.435579,0.446272,1.25393,0.974632,0.864173,0.428662,0.767269,0.612377,0.763807,0.573477,0.0206035
}}
}}

Revision as of 19:25, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr13:52192094..52192116,+p1@4921525O09Rik
Mm9::chr17:30788593..30788615,+p@chr17:30788593..30788615
+
Mm9::chr17:30788624..30788646,+p@chr17:30788624..30788646
+
Mm9::chr17:30815513..30815518,+p@chr17:30815513..30815518
+
Mm9::chr17:30821766..30821771,+p@chr17:30821766..30821771
+
Mm9::chr9:114277586..114277594,+p2@ENSMUST00000131898
p2@uc009rxf.1
p2@uc012hca.1
Mm9::chr9:64766451..64766491,-p@chr9:64766451..64766491
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
hemopoietic organ1.60e-1729
immune organ1.60e-1729
thymus1.48e-1623
neck1.48e-1623
respiratory system epithelium1.48e-1623
hemolymphoid system gland1.48e-1623
pharyngeal epithelium1.48e-1623
thymic region1.48e-1623
pharyngeal gland1.48e-1623
entire pharyngeal arch endoderm1.48e-1623
thymus primordium1.48e-1623
early pharyngeal endoderm1.48e-1623
respiratory tract2.41e-1641
respiratory system8.55e-1642
pharynx1.15e-1524
gland of gut1.15e-1524
upper respiratory tract1.15e-1524
chordate pharynx1.15e-1524
pharyngeal arch system1.15e-1524
pharyngeal region of foregut1.15e-1524
mixed endoderm/mesoderm-derived structure1.49e-1335
segment of respiratory tract2.11e-1327
hemolymphoid system7.32e-1348
immune system7.32e-1348
foregut7.40e-1380
digestive system1.81e-12116
digestive tract1.81e-12116
primitive gut1.81e-12116
endoderm-derived structure4.42e-12118
endoderm4.42e-12118
presumptive endoderm4.42e-12118
subdivision of digestive tract5.56e-12114
hematopoietic system1.79e-1145
blood island1.79e-1145
endo-epithelium7.30e-1169
organ segment1.21e-1035
craniocervical region6.43e-0936
gut epithelium1.23e-0755
anterior region of body8.92e-0743


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}